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Sulnlnllry 
The effects of human immunodeficiency  virus 1 (HIV-1) infection on cdlular differentiation and 
NF-xB DNA binding activity have been investigated in a new model of myeloid differentiation. 
PLB-985 cells represent a bipotential myelomonoblastic cell population capable of either granulocytic 
or monocytic differentiation after induction with appropriate inducers. By virtue of the presence 
of CD4 on the cell surface, PLB-985 cells were chronically infected with HIV-1 strain IIIB. PLB- 
IIIB cells clearly possessed a more monocytic phenotype than the parental myeloblasts, as determined 
by differential staining, increased  expression of the myeloid-specific  surface markers, and transcription 
of the c-f  ms proto-oncogene. NF-gB binding activity was inducible by tumor necrosis factor 
and phorbol myristate acetate in PLB-985. However in PLB-IIIB cells, constitutive expression 
of a novel NF-KB complex was detected, composed of proteins ranging between 70 and 110 kD. 
These proteins interacted specifically  with the symmetric NF-xB site from the interferon/~ (IFN-/~) 
promoter. Mutations affecting the 5' guanine residues of the KB site were unable to compete 
for these NF-KB-related proteins.  Inducibility of endogenous IFN-/~ and IFN-o~ RNA was also 
increased in PLB-IIIB cells. These studies indicate that HIV-1 infection of myelomonoblastic 
ceils may select for a more mature monocytic phenotype and that unique subunit associations 
of NF-xB DNA binding proteins may contribute to differential NF-KB-mediated gene expression. 
T 
he host range of the HIVol  includes,  in addition to 
CD4 + Th lymphocyte, ceils of the monocyte/macro- 
phage  lineage,  and hematopoietic progenitor cells  (1-3). 
Whereas Th cells are ultimately destroyed by HIV infection, 
infection of monocytic cells is not cytolytic, and these calls 
may act as reservoirs for viruses, thus contributing to virus 
spread to peripheral tissues including the lungs, brain, skin, 
and lymph nodes (3).  Furthermore, HIV infection of my- 
eloid cells results in the impairment of crucial functions in- 
volved in host defense, such as antigen presentation,  chemo- 
taxis,  cell killing, and cytokine release (4-6). 
HIV-1 infection of PBMC and monocytes/macrophages may 
have a dramatic impact on cellular gene expression and in 
particular on cytokine production (7-17). HIV infection does 
not generally lead to constitutive cytokine gene transcrip- 
tion and secretion (9, 12, 13); however, the cytokine response 
of HIV-infected cells to subsequent  antigenic challenge by 
viruses, lipopolysaccharides, or poly(I:C) can be affected in 
1 A. Roulston and M. D'Addario were equal contributors to this work. 
HIV-infected cultures, often leading to increased expression 
of TNF and IL-1 (9, 12, 15-17). Cytokine release by HIV- 
infected ceils may, in turn, alter the course of virus patho- 
genesis in vitro. For example, treatment of cells with TNF-ot, 
Ibl, or GM-CSF has been shown to increase gene expression 
driven by the HIV-1 LTR in transfection studies, and to stimu- 
late virus multiplication in vitro (10, 11,  18-21). 
Cytokines, phorbol esters, virus infections, double-stranded 
RNA, and other mitogenic agents potentiate HIV replica- 
tion, in part via activation of NF-KB, a family of mitogen- 
and  phorbol-ester-inducible  DNA  binding  transcription 
factors which bind to and activate the HIV enhancer (22-24). 
NF-KB proteins bind to a decameric recognition sequence (con- 
sensus  5'-GGGRNNYYCC-3')  present  in  the  promoter 
regions of many cellular genes encoding immunoregulatory 
molecules (Ib2 receptor-o~, MHC class I antigens, and TNF 
receptor) and cytokines (Ib2, II.-6, IL-8, IFN-3, TNF, and 
GM-CSF), as well as the enhancer domains of several viruses 
(22). To date, NF-IcB induction has been characterized pre- 
dominantly as a posttranslational  event. Latent NF-KB exists 
in the cytoplasm as a heterotrimeric protein;  induction in- 
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tory protein (inhibitor of rB or ItcB), and nuclear transloca- 
tion  of the DNA-binding  NF-rB  complex  (22,  25,  26). 
Phosphorylation of IrB appears to be a necessary requirement 
for dissociation of the heterotrimeric form of NF-rB (22). 
Recent cloning of the p65 and p50 subunits has revealed that 
the NH2-terminal DNA binding region of both proteins 
shares homology  with the c-tel proto-oncogene, (27-32).  Fur- 
thermore these studies indicate that NF-rB induction may 
also be controlled at the level of transcription. 
As a step toward understanding the consequences of HIV-1 
infection on myeloid differentiation and cellular gene expres- 
sion, we have investigated the induction of monocytic  differen- 
tiation and NF-rB/rel activities in a new myelomonoblastic 
model of HIV-1 infection. PLB-985 cells represent an imma- 
ture blast population, capable of  both monocytic  and granulo- 
cytic differentiation (33).  By virtue of CD4 expression  on 
the cell surface, these cells were infected by HIV-1 strain IIIB 
and a chronically infected line (PLB-IIIB) was established. 
Characterization of PLB-IIIB cells and NF-rB-related activity 
has demonstrated that HIV-1 infection of myelomonoblastic 
cells may select for a more mature monocytic phenotype, and 
that distinct subunit associations  of NF-rB DNA binding 
proteins may contribute to developmental and inducible NF- 
rB-mediated gene expression. 
Materials and Methods 
Cell Culture 
Myelomonoblastic  PLB-985 and PLB-IIIB  cells were maintained 
at 370C, 5% CO2, in RPMI 1640 medium (Gibco Laboratories, 
Grand Island, NY) supplemented with 10% FCS, 1% glutamine, 
1,000 IU/ml penicillin, 20/zg/ml streptomycin, and 1/xg/ml gen- 
tamycin. Induction of exponentially growing ceils was performed 
as described  for the individual  experiments. Cells were treated with 
PMA (Sigma Chemical Co., St. Louis, MO) to a final  concentra- 
tion of 25 ng/ml, DMSO (Aldrich Chemical Co.) to a final  con- 
centration of 1.25%, 2'-dibutyryl adenosine-Y, 5'-cyclic  monophos- 
phate (Bt2cAMP; Sigma Chemical Co.) to a final concentration of 
750/zM, cis-retinoic acid (R.A; Sigma Chemical Co.) to a final  con- 
centration of 1/~M, and TNF-c~ to a final concentration of 100 
U/ml. 
Infection of PLB-985 
Cells were infected using supernatant HTLV-IIIB  virus obtained 
from U9-IIIB cells as previously described (34). 
P24 Antigen Determination 
Immunofluorescence.  Production of HIV-l-specific p24 antigen 
was monitored over a period of 60 d by indirect immunofluores- 
cence. Cells were fixed on multibeveled slides with methanol/ace- 
tone (1:1). An aliquot of mouse anti-p24  antibody (a gift from 
Dr. R. Gallo, National Institutes of Health, Bethesda, MD) diluted 
1:1,000 in PBS was added to each well for 30 rain. After washing 
with PBS, goat anti-mouse-conjugated FITC antibody (diluted 
1:1,000 in PBS) (Caltag Laboratories, San Francisco,  CA) was added 
for 30 min. Slides  were washed with PBS plus 0.25% Triton X-100, 
air-dried, and mounted with glycerol. 
ELISA.  An ELISA  (Abbott Labs, North Chicago, IL) was used 
to detect HIV-1 p24 in culture fluids, as per manufacturer's in- 
structions. 
Reverse Transc@tase Analysis 
At different time points after infection 1 ml of culture medium 
was centrifuged at 1,200 rpm for 10 rain. Keverse transcriptase ac- 
tivity was evaluated  without further virus concentration using 3H 
TTP incorporation into acid-precipitable nucleic acid (34). 
Analysis  of RNA 
Total cellular  R.NA was isolated  from untreated and PMA-treated 
PLB-985 and PLB-IIIB cells at specific times using a modified 
guanidinium isothiocyanate procedure (35). Total RNA (20/xg) 
was electrophoresed  in a 1% denaturing formaldehyde  gel, trans- 
ferred to a nylon membrane, and hybridized  with ~-[32P]ATP nick 
translated probes at 42~  The probes include a 1.23-kb c-f  ms frag- 
ment generated by EcoKI cleavage of clone pc-fins 104 (American 
Type Culture Collection, Rockville, MD), a 1.1-kb/~-actin frag- 
ment, a 4.5-kb c-roTe fragment containing exons 2 and 3 produced 
by cleavage of plasmid pHSK-1 (American Type Culture Collec- 
tion) with XbaI, EcoRI, and HB10, a 12.5-kb HIV-IIIB probe (a 
gift from Dr. F. Wong-Staal,  University of California  at San Diego, 
La Jolla, CA). The blots were washed at 55-60~  air-dried, and 
exposed to X-OMAT film (Kodak)  at - 70~  The relative  amounts 
of  each signal were quantified  by laser  densitometry (Ultrascan XL; 
Pharmacia LKB Biotechnology Inc., Piscataway, NJ). 
Analysis  of Surface Markers 
PLB-985 and PLB-IIIB ceils treated with PMA or retinoic acid 
were analyzed for expression of myeloid specific surface markers 
using mAbs directed against CD13, CD14, CD33,  CD34,  and 
CD67 and analyzed  in an Epics Profile  II cytofluorograph;  (Coulter 
Electronics, Hialeah, FL). 
Whole Cell Extract Preparations 
Whole cell extracts (WCE)  z were prepared from  untreated 
PLB-985 and PLB-IIIB  cells or from cells treated for 6 or 15 h with 
PMA (25 ng/ml) or TNF-~ (100 U/ml) as previously  described (24). 
Gel Retardation Assays 
Cell protein in WCE buffer (0.1 M KC1), was preincubated  with 
5/zg of poly(dI:dC) as nonspecific  competitor DNA for 10 min 
on ice. 32p-labeled probe (0.2 ng) consisting of the P2 oligonucle- 
otide (5'-GC~AAA.TTCCGC~AAATTCC-Y)  or the HIV enhancer 
(5'-AGGGACTTTCCGC'/GGC,  GACTTTCC-Y) was added to the 
protein, and incubated for 30 min at room temperature. Competi- 
tion assays  were performed by incubating 125-fold excess of unla- 
beled competitor (25 ng) with the protein for 10 min on ice, before 
the addition of radiolabeled probe. 
UV Crosslinking Analysis 
For UV crosslinking  analysis,  assays  were performed  using double- 
stranded BUdR-substituted UPqabeled P2 or HIV oligonucleotide 
probes. The crosslinking procedure was performed as previously 
described (36). 
2 Abbreviation used in this paper: WCE, whole cell extract(s). 
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Total RNA was isolated  from uninduced or Sendal  virus-induced 
PLB-985 or PLB-IIIB cells. Ceils were IFN-~x  primed (250 U/ml), 
then treated with Sendai  virus (2,000 HAU/ml) for 6 h before RNA 
isolation. IFN-ot- and IFN-B-specific RNA was analyzed  by PCR- 
mediated RNA phenotyping as previously described (9) using the 
IFN-cx (sense:  5'-CAATAIL'TAC~GC-3'  and antisense 
5'CAGAAGC~TCCAGCCATCTCT-3')  and IFN-B primers de- 
scribed previously (12). 
Resuks 
Isolation and C~racterization Of  PLB-IIIB Cells.  PLB-985 
cells were originally derived from a patient with acute non- 
lymphocytic leukemia and characterized as  a  diploid  my- 
elomonoblastic cell line (33).  PLB-985  cells are capable of 
differentiation along the monocytic lineage after treatment 
with phorbol esters or along the granulocytic lineage after 
treatment with agents such as DMSO, dibutyryl cAMP, or 
retinoic acid (33).  By virtue of the expression of CD4 on 
the surface of >99% of the calls, PLB-985 ceils were infected 
with HIV-IIIB using culture fluids of HIV-l-infected U937 
cells 04).  At various times after infection, the ceils and/or 
culture fluids were assayed for RT activity, p24 core antigen, 
and accumulation of viral RNA (Fig.  1). After a lag period 
of about 10 d, the number of  p24-positive cells increased rap- 
idly together with levels of RT. By day 18, more than 50% 
of the population was infected with HIV-1 (Fig. 1A). Spliced 
and unspliced viral RNA spedes were easily detectable by 
Northern blot  analysis  using the HB10 probe (Fig.  1 B). 
During the next several weeks, the infected cell population 
underwent considerable death, presumably because of rapid 
virus multiplication. Within 2 too, a chronically infected cell 
population  (>95%  positive  for  p24  antigen  and  <4% 
CD4 +) emerged that possessed  a more mature monocytic 
phenotype than the immature parental blast ceils (compare 
Fig. 2, A  and C). Phorbol ester treatment of PLB-985 pro- 
duced an adherent, monocyte-like phenotype (Fig.  2 B). In 
contrast, PLB-IIIB without induction displayed several char- 
acteristics of  monocyte maturation, including less basophilic 
cytoplasm, decreased nuclear/cytoplasmic ratio,  production 
of vacuoles,  less visible nucleoli, ruffling at the cytoplasmic 
membrane, and lobularization of  the nucleus (Fig. 2 C). PMA 
treatment of the PLB-IIIB ceils further acxentuated these fea- 
tures of the monocytic phenotype (Fig.  2 D). 
Expression of Myeloid Specific Suoface Markers.  To deter- 
Figure 1.  Kinetics  of infection  of PLB-985 cells  by HIV-1. (A) The kinetics  of infection  were assessed  by p24 core antigen  immunofluorescence 
(I) and by analysis  of reverse  transcriptase  activity  (O) in culture supernatants  at various times after initial infection.  (B) Detection  of HIV-1 viral 
RNA species in chronically  infected  PLB-IIIB ceils. Total RNA (20/~g) from FLB-985 (lane 1) and/or PLB-IIIB (lane  2) was electrophoresed  in a 
1% formaldehyde  gel, transferred  to a nylon filter (Amersham  Corp.), and hybridized  with the HB10 probe. 
753  Roulston  et al. Figure 2.  Morphological characteristics  of  PLB-985 and PLB-IIIB cells. PLB-985 cells (A and B) and PLB-IIIB (C and D) were fixed and differentially 
stained with Giemsa and examined  by phase contrast microscopy.  Cells were either untreated (A and C) or PMA treated for 6 h (B and D) before staining, 
mine whether the morphological alterations  were accompa- 
nied by other changes in the PLB-IIIB phenotype, expres- 
sion of myeloid-specific  markers was  determined by flow 
cytometry.  PLB-985  cells  were  <5%  positive  for  the 
monocyte-specific  marker CD14, whereas the PLB-IIIB cells 
were about 20%  positive for the monocyte-specific CD14 
surface antigen. After PMA treatment, PLB-IIIB cells be- 
came >60% CD14 positive within 24 h (Fig. 3 A). The levels 
of other mydoid markers CD13, CD33, and CD67 remained 
at >90%. Similarly 5-15% of the cells were CD34 positive 
both before and after infection (Fig.  3 B). 
Expression of elms and c-myc Proto-oncogenes.  Alteration of 
proto-oncogene  expression is a recognized consequence of in- 
duction of differentiation in a variety of hematopoietic cell 
types (37, 38). To examine the effects of HIV-1 infection on 
PMA-induced proto-oncogene expression,  the steady  state 
mRNA levels for c-myc and c-fras were measured at different 
times after PMA treatment of PLB-985  and PLB-IIIB cells 
(Fig. 4). In both cell types, c-myc  RNA levels  decreased about 
2-3 fold by 24 h after PMA treatment (Fig. 4, upper). In con- 
trast, c-f  ms RNA was only weakly detectable by Northern 
blot analysis in PLB-985 cells before or after PMA induction 
(Fig. 4, middle, lanes 1-5). In untreated PLB-IIIB cells, c-f  ms 
RNA was present in low quantities. This level of c-f  ms was 
induced more than 20-fold by PMA treatment (Fig. 4, middle, 
lanes  6-10).  The level of B-actin ILNA did not  fluctuate 
significantly with induction or differentiation (Fig. 4, bottom). 
After granulocyte induction of PLB-985 and PLB-IIIB cells 
with dibutyryl cAMP, no increase in c-f  ms was observed (data 
not shown). Finally, morphological and histochemical studies 
demonstrated that PLB-IIIB cells were nonresponsive to in- 
ducers of granulocytic differentiation, indicating that the cell 
population had irreversibly  differentiated  along the mono- 
cytic lineage (data  not shown). 
Induction  of NF-r,B  Binding  Activity  in  PLB-IIIB  Cells. 
Previous  studies have demonstrated a correlation between 
monocyte maturation and the expression of NF-tcB DNA 
binding activity (39-41).  More recently,  NF-gB has been 
shown to represent a family of rel-related DNA binding pro- 
teins involved in both transcriptional control and oncogen- 
esis (reviewed in references 22, 27-32). We therefore sought 
to examine the relationship between HIV infection, mono- 
cytic differentiation, and activation of the NF-tcB/rel tran- 
scription complex in this new myelomonoblastic model of 
HIV-1 infection. Induction of NF-gB DNA binding activity 
was examined after treatment with PMA or TNF-cr  using 
754  NF-~B  Activity in HIV-l-infected  Monocytic Cells Figure 3.  Myeloid-specific  surface  marker expression.  PLB-985  and PLB- 
IIIB cells were either untreated or PMA treated for various times before 
surface marker analysis using the EPICS cytofluorograph (Coulter Elec- 
tronics Inc.).  (/1) The percentage of CD14 positive cells is plotted as a 
function of time after PMA treatment. (e) PLB-IIIB; (O) PLB-985. (B) 
The levels of CD13-, CD33-, and CD34-positive PLB-985 ([]) and PLB- 
IIIB (11) cells. 
the P2 oligonucleotide which consists of two copies of the 
NF-KB site found in IFN-t3 (PRDII site,  -64 to  -55) and 
human c-tel (-28 to -18) or the HIV enhancer oligonucle- 
otide which contains two NF-KB-binding sites found in the 
HIV-1  LTR  (-105  to  -80).  In  PLB-985  cells,  multiple 
protein-DNA complexes were induced by 5 or 16 h of PMA 
or TNF treatment. Both inducers appeared to be equally effec- 
tive in stimulating NF-KB-DNA binding activities  (Fig.  5 
A, lanes 1-3 and 7-9). In PLB-IIIB cells, a distinct pattern 
of protein-DNA complex formation (complex A) was de- 
tected consisting of strong constitutive P2 DNA binding ac- 
tivity; formation of slowly migrating complexes; and weak 
inducibility of this DNA binding activity by either PMA 
or TNF (Fig.  5 A, lanes 4-6 and I0-12).  A similar profile 
was observed using the HIV enhancer sequence as probe al- 
though about fivefold less complex A was detected with this 
probe (Fig.  5 B). In competition experiments, both the P2 
oligonucleotide and the HIV enhancer oligonucleotide  were 
able  to  compete effectively  for  the  TNF-induced NF-KB 
binding activities in PLB-985 cells (Fig. 6 A). However, in 
PLB-IIIB cells only the P2 probe (Fig. 6 B, lanes 2, 5, and 
8) competed efficiently for the slower migrating constitutive 
A  complex. The HIV enhancer competed weakly for this 
DNA binding activity (Fig. 6 B, lanes 3, 6, and 9). In dis- 
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sociation rate analysis, complex A  dissociated from the ra- 
diolabeled probe with a TI,~ of <4 min in the presence  of 
excess P2 oligonucleotide, whereas addition of excess HIV 
enhancer failed to dissociate the A complex (T~ >30 min) 
(Fig. 7). Thus, the proteins involved complex A bound pref- 
erentiaUy to the 5'-GGGAAATTCC-3' site. These proteins 
had a >20-fold higher affinity for P2 sequences than for HIV 
enhancer sequences. 
To evaluate the sequence specificity of complex A binding, 
mutational analysis of the NF-xB sites was performed. Mu- 
tations that altered  the 5' guanine residues  of the HIV or 
P2 oligonucleotides completely inhibited NF-gB competition 
in PLB-985 extracts (Fig. 8 A, lanes 3 and 5), whereas muta- 
tion of the AA dinucleotide to CG partially inhibited >60% 
of the NF-KB binding (Fig. 8 A, lane 6). With extracts from 
PLB-IIIB cells, only the homologous P2 oligonucleotide  com- 
peted effectively for complex A (Fig. 8 A, lane 10). Mutation 
of either the 5' guanine residues or the AA dinucleotide of 
the NF-KB site blocked competition (Fig. 8 A, lanes 1I and 
12). These results suggest that complex A is composed of 
NF-xB  related  proteins that require the entire P2 site for 
efficient DNA binding. 
The proteins involved in protein-DNA complex forma- 
tion were evaluated by in situ UV crosslinking analysis using 
BUdR-substituted 1)2 and HIV enhancer probes together with 
extracts  from the TNF-treated PLB-985  or PLB-IIIB cells 
(Fig. 9). The regions of the mobility shift assay corresponding 
to NF-KB and complex A were cut from the gel (Fig. 9 A), 
crosslinked in situ for 30 rain and resolved on an SDS poly- 
acrylamide gel (Fig. 9 B). Both P2 and HIV probes bound 
proteins of 50, 40, and 20 kD from PLB-985  cell extracts 
(Fig.  9 B, lanes  I  and 2).  In addition, proteins of 75 and 
60 kD interacted weakly with the HIV enhancer. Differences 
in protein migration were attributable to the size difference 
between the two probes.  It is striking that the HIV probe 
did not effidently bind proteins from the PLB-IIIB extracts 
(Fig. 9 B, lane 4), whereas multiple proteins ranging in size 
from 50-105  kD were detected using the P2 probe (Fig.  9 
B, lane 3). Three prominent proteins of 100, 90, and 70 kD 
were identified, as well as several other proteins. Compar- 
ison of uninduced and TNF induced extracts  by UV cross- 
linking also demonstrated that only the 70-kD protein was 
inducible by TNF (data not shown). Overall, the profiles of 
NF-xB DNA binding proteins in PLB-985 and PLB-IIIB cells 
differ dramatically,  indicating that the nature of NF-gB-like 
interactions is altered  in the HIV-infected cells. 
Transcription of IFN-ot  and IFN-~ Genes.  To examine if 
changes in the state of differentiation or NF-xB-related ac- 
tivities affected gene expression, the transcription of IFN-c~ 
and IFN-B genes was investigated in PLB-985 and PLB-IIIB 
cells (Fig.  10). In PLB-985 cells, IFN-~ KNA was induced 
by Sendai virus infection 6 h after infection. In PLB-IIIB cells, 
a low level of constitutive IFN-~ mRNA was detected and 
coinfection  by Sendai virus resulted in three- to fourfold more 
IFN-/3 KNA than similarly induced PLB-985 cells. In con- 
trast to these results,  IFN-ot transcription was only weakly 
induced in PLB-985 cells, but 50-fold higher levels of IFN-ot 
KNA were detected in PLB-IIIB cells. Together, these results Figure 4.  Modulation ofc-myc and c-f  ms RNA levels in PMA-treated PLB-985 and PLB-IIIB cells. Total RNA (20/xg) from PMA-treated PLB-985 
cells (lanes I-5) or PLB-IIIB cells (lanes 6-10) was dectrophoresed  in a 1% formaldehyde gel, transferred to a nylon membrane, and hybridized sequen- 
tially with c-myc, c-f  ms, and 3-actin probes as described in Materials and Methods.  R.NA was isolated at 0, 2, 6, 10, and 24 h after treatment (shown 
below the autoradiogram).  The arrows indicate the positions  of the correct  RNA signal. 
indicate that HIV infection of myelomonoblastic  cells results 
in selection of a cell population with a more monocytic  pheno- 
type by several criteria, changes in NF-rB-like protein-DNA 
interactions and modulation of cytokine gene expression. 
Discussion 
HIV-1 infection of PLB-985 blast cells resulted in the gener- 
ation of a chronically infected cell population (PLB-IIIB) pos- 
sessing morphological, immunological, histochemical, and 
molecular characteristics  of monocytes. Concomitant with 
HIV infection and myeloid differentiation, dramatic altera- 
tions in the protein-DNA interactions occurring at the NF- 
KB  recognition sequence  5'-GGGAAATTCC-3'  were ob- 
served. Distinct proteins of 100, 90, and 70 kD were identified 
in PLB-IIIB cells that possessed a higher affinity for the more 
symmetric PRDII binding site than for the HIV enhancer 
sites. These two sequences differ only by the -AA- and -CT 
dinucleotides in the middle of the binding site, resulting in 
a more palindromic recognition sequence. 
NF-rB represents a family of rel-rehted DNA binding poly- 
peptides that include p45, p50, p55, p65, p75, and p85 (c- 
tel).  The activities of these proteins are controlled at several 
regulatory levels. Multiple DNA binding NF-KB heterodi- 
mers with distinct affinities for DNA can form in vitro (22, 
42, L. Cohen andJ. Hiscott, manuscript submitted for pub- 
lication), single base changes in the NF-r.B site can significantly 
alter the binding affinity of these heterodimers. Biphasic ki- 
netics of NF-KB induction has been described,  characterized 
by rapid appearance of p55 and p75 forms of NF-rB within 
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 Figure  6.  (A) Competition of NF-gB-binding proteins 
in PLB-985 cells. The protein-DNA comple~as present 
in uninduced  (lane I), 5-h TNF-treated  (lane 4) or 16-h 
TNF-treated (lane 7) extracts were competed using a 125- 
fold excess of unlabeled P2 oligonucleotide  (lanes 2, 5, 
and 8) or unlabeled HIV enhancer oligonucleotide (lanes 
3, 6, and 9). The bracket indicates the position of NF-~B 
complexes; and the arrow indicates the nonspecific (ns) 
complex.  (B) Competition NF-~B-binding  proteins  in 
PLB-IIIB cells. The protein-DNA complexes present in 
uninduced (lane 1), 5-h TNF-treated (Lane  4), or 16-h  TNF- 
treated (lane 7) extracts were competed using a 12S-fold 
excess of unlabeled P2 oligonucleotide  (lanes 2, 5, and 
8) or unlabeled HIV enhancer oligonucleotide  (lanes 3, 
6, and 9). The arrows indicate the position of the slowly 
migrating  A complex and the nonspecific complex. 
minutes, and by the delayed induction of p50 and p85 after 
several hours of PMA treatment (32). These observations in- 
dicate that variations  in DNA  af~nity,  heterodimer  forma- 
tion, and induction kinetics may contribute to both positive 
and negative transcriptional  control. 
With the availability of cloned NF-gB subunits, it is now 
clear that transcription of NF-KB-related genes represents an- 
other important level  of regulation.  NF-gB  p50,  IgB,  and 
c-rel gene transcription is rapidly induced by phorbol esters 
and mitogens (29, 43-45). Furthermore,  a new NF-gB 100- 
kD precursor gene was described recently  that is regulated 
by both alternate splicing and proteolytic cleavage to yield 
two forms of a distinct p50 subunit (52).  HIV-1  infection 
may have an impact on posttranslational processing of NF-KB 
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Figure  7.  Dissociation  rate analysis of the P2 complex. The P2 probe 
(0.2 ng) was mixed with protein from TNFqnduced PLB-IIIB cells (10 
~g) in the presence of 5/~g of poly(dI:dC) as nonspecific competitor; at 
To, the amount of complex A was determined. A  125-fold molar excess 
of P2 oligonuclentide or HIV enhancer oligonucleotide was added to the 
reaction, and at 2-min intervals the amount of complex A remaining was 
measured. The rehtive intensity of the bands at different times was quantified 
by laser densitometry and plotted as a function of the amount of complex 
at To.  (e) P2;  (O) HIV. 
since the p105 precursor may be cleaved by the HIV-1 pro- 
tease in vitro (46). 
Several possibilities  may account for the dramatic differ- 
ences in DNA binding activity between PLB-985 and PLB- 
IIIB cells. The induction of distinct or NF-KB-related  pro- 
teins in PLB-IIIB cells may occur as a result of monocytic 
differentiation. Recent studies indicate that c-rel may be tran- 
scriptionally induced in PLB-IIIB cells (data not shown). Al- 
tered stoichiometry of NF-KB subunits because of changes 
in precursor processing may result in binding of larger,  in- 
completely processed  subunits. The 100- and 105-kD pS0 
precursors may not be processed efficiently in PLB-IIIB cells, 
resulting in the formation of new combinations of DNA- 
binding heterodimers, possibly via interactions of the ankyrin 
repeat. Overexpression of chromatin-associated  proteins may 
stabilize the binding of proteins that would otherwise possess 
an affinity too low to be detected by mobility shift analysis. 
Recently a protein capable of interacting with the PRDII 
site but not other NF-KB sites has been described that may 
act as such an accessory  protein and, in part, explain the unique 
pattern of NF-gB binding observed only in the PLB-IIIB cells 
(47). The HMG I/Y proteins are chromatin-associated pro- 
teins that bind in the minor groove of DNA to sequences 
that are A-T rich or that possess Oct-1 like recognition sites 
Figure  8.  Mutational analysis of the 
NF-KB-binding sites. (A) The protein- 
DNA complexes  present in PLB-985 
cells (lane I) and PLB-IIIB cells (lane 
7)  were  competed  using  a  125-fold 
e~ess of unlabeled oligonucleotide cor- 
responding to the HIV enhancer (lanes 
2 and 8), the HIV mutated enhancer 
(lanes 3 and 9), the P2 oligonucleodde 
(Lanes 4 and 10), the P2 mutant A (lanes 
5 and 11), and the P2 mutant B (lanes 
6 and 12). The sequence of these oligo- 
nudeotides is  shown  adjacent  to the 
quantification data. Altered nucleotides 
relative to the sequence of wild-type  P2 
are  indicated  by  small  letters.  (B) 
Quantification of mutant competition. 
The amount of DNA binding activity 
remaining after competition was mea- 
sured  by  laser  densitometry  and 
quantified relative  to  the  amount  of 
binding obtained without competitor. 
The  results represent  the  average  of 
duplicate competition experiments. (t~) 
amount  of complex remaining from 
PLB-985 extracts; (I) amount of com- 
plex remaining from PLB-IIIB extracts. Figure 9.  UV crosslinking  analysis  of pro- 
teins  binding to HIV and P2 oligonucleotides. 
(A) Mobility shift analysis  of NF-r.B binding 
activities in PLB-985 (lanes I and 2) and PLB- 
IIIB (lanes  3 and 4) after treatment with TNF 
for 5 h using BUdR substituted, szP-labeled 
P2 (lanes  1 and 3) or HIV (lanes  2 and 4) probes. 
The nonspecific  complex  (ns) was not analyzed. 
(B) The region of the gel containing NF-xB 
complex A was cut from the native gel, ex- 
posed to UV (302 nm) for 30 rain, soaked  in 
SDS sample  buffer,  and analyzed  on a 10% SDS 
polyacrylamide  gel. The positions  of  molecular 
mass standards (M) are indicated; the molec- 
uhr masses  of  crosslinked  proteins  are indicated 
with arrows. 
(48,  49).  Increased HMG I/Y protein levels  have been de- 
tected in undifferentiated, rapidly growing and transformed 
cells (50,  51).  HIV-1  infection may be sufficient to increase 
HMG I/Y levels  in PLB-IIIB cells. 
In parental PLB-985 cells, PMA treatment resulted in the 
induction of NF-KB binding activity and monocytic differen- 
tiation. These results are in agreement with previous studies 
that showed that NF-KB binding activity, expression of an 
HIV-LTR reporter gene, and monocytic differentiation were 
coordinately inducible in immature myeloid cells (HI.,60 and 
U937).  In the more mature P388, THP-1, and P45-1.8 cells, 
and in primary macrophages, binding activity and basal level 
expression of the HIV-LTR reporter gene were constitutive 
and not further inducible,  suggesting that NF-KB binding 
activity is induced during the promyelocytic to monocytic 
transition (39).  However, in other studies,  NF-KB binding 
760  NF-gB  Activity in HIV-l-infected Monocytic Cells Figure 10.  Transcription  of IFN oL//~  genes. Total  RNA was isolated 
from PLB-985 and PLB-IIIB  cells after Sendai virus induction  for 6 h. 
Reverse  transcription  and PCR-medhted  amplification  was carried  out using 
1/~g of RNA and 321Mabeled  IFN-o~ and IFN-~ consensus  primers (12). 
The products of amplification  were resolved  by denaturating  polyacryl- 
amide  gel electrophoresis.  The relative  RNA levels  were  quantified  by laser 
densitometry  of autoradiographs and presented as a bar graph. 
activity was not induced by HIV infection of U937  cells. 
It is interesting that these experiments identified but did not 
further characterize a virus induced, slowly migrating protein- 
DNA complex associated  with the HIV enhancer (40).  In 
primary monocytes, both NF-rB and slowly migrating com- 
plexes were induced in response  to HIV infection (40). The 
PLB cell line represents a relevant new myeloid model to in- 
vestigate the relationship between HIV infection, monocytic 
differentiation,  and the induction of these novel NF-rB related 
activities.  It will nonetheless be important to evaluate  the 
results obtained with the cell model in light of findings with 
primary monocytic  cells. Given the abundant regulatory levels 
of NF-rB activity, it appears that whether developmentally 
regulated or induced by HIV infection, NF-rB provides a 
range of potent signals for stimulation of HIV gene expres- 
sion and cytokine activation. 
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